TCM Ltd
Incorporated in 1943, TCM Ltd manufactures chemicals having and trades solar equipments and healthcare devices[1]
- Market Cap ₹ 29.8 Cr.
- Current Price ₹ 39.8
- High / Low ₹ 79.5 / 35.0
- Stock P/E
- Book Value ₹ 36.4
- Dividend Yield 0.00 %
- ROCE -7.04 %
- ROE -6.55 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.09 times its book value
- Debtor days have improved from 175 to 96.4 days.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -10.6% over last 3 years.
- Company's cost of borrowing seems high
- Working capital days have increased from -337 days to 100 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
0.40 | 0.92 | 4.23 | 3.55 | 7.35 | 32.23 | 26.95 | |
1.26 | 1.75 | 5.11 | 7.56 | 11.01 | 34.45 | 29.82 | |
Operating Profit | -0.86 | -0.83 | -0.88 | -4.01 | -3.66 | -2.22 | -2.87 |
OPM % | -215.00% | -90.22% | -20.80% | -112.96% | -49.80% | -6.89% | -10.65% |
0.04 | 1.15 | 1.23 | -1.69 | 0.02 | 0.43 | 0.47 | |
Interest | 0.12 | 0.01 | 0.01 | 0.01 | 0.28 | 0.16 | 0.30 |
Depreciation | 0.00 | 0.01 | 0.03 | 0.17 | 0.37 | 0.30 | 0.35 |
Profit before tax | -0.94 | 0.30 | 0.31 | -5.88 | -4.29 | -2.25 | -3.05 |
Tax % | 0.00% | 0.00% | 61.29% | 0.00% | -0.70% | 1.78% | |
-0.95 | 0.30 | 0.12 | -5.88 | -4.27 | -2.29 | -3.08 | |
EPS in Rs | -1.27 | 0.40 | 0.16 | -6.85 | -5.35 | -2.61 | -3.70 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 141% |
3 Years: | 97% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -5% |
Stock Price CAGR | |
---|---|
10 Years: | -1% |
5 Years: | 7% |
3 Years: | 0% |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -6% |
3 Years: | -11% |
Last Year: | -7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 7.48 | 7.48 | 7.48 |
Reserves | 29.02 | 29.07 | 29.19 | 21.93 | 23.26 | 21.31 | 19.76 |
5.38 | 5.64 | 5.83 | 6.53 | 1.44 | 0.27 | 0.15 | |
31.35 | 27.33 | 29.32 | 29.58 | 36.63 | 54.74 | 54.23 | |
Total Liabilities | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 81.62 |
58.01 | 58.01 | 58.82 | 55.28 | 35.70 | 17.28 | 9.11 | |
CWIP | 0.00 | 0.00 | 0.06 | 0.02 | 0.10 | 0.10 | 0.00 |
Investments | 0.44 | 0.19 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 |
10.70 | 7.24 | 8.68 | 6.14 | 33.01 | 66.42 | 72.51 | |
Total Assets | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 81.62 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
-1.63 | -0.57 | 0.39 | -4.21 | -10.87 | 1.95 | |
0.01 | 0.00 | -0.51 | 4.22 | 5.84 | -0.64 | |
5.32 | -3.14 | 0.18 | 0.19 | 4.87 | -1.30 | |
Net Cash Flow | 3.69 | -3.70 | 0.06 | 0.20 | -0.15 | 0.00 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 1,377.88 | 706.20 | 217.45 | 195.35 | 232.90 | 96.37 |
Inventory Days | 1,477.38 | 847.92 | 467.90 | 192.33 | 269.66 | 852.04 |
Days Payable | 2,581.07 | 1,914.85 | 743.59 | 77.21 | 91.78 | 78.57 |
Cash Conversion Cycle | 274.18 | -360.73 | -58.24 | 310.47 | 410.78 | 869.84 |
Working Capital Days | -6,077.25 | -1,023.59 | -314.95 | -691.96 | -419.13 | 100.11 |
ROCE % | 0.82% | -0.16% | -10.58% | -12.90% | -7.04% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Acquisition
10h - TCM Limited to acquire 100% stake in Better Feeds Pvt Ltd for Rs.7.65 crore, expanding feed business.
-
Board Meeting Intimation for Declaration Of Audited Financial Results For The Quarter And Year Ended 31St March 2025
1d - Board meeting on 29 May 2024 to approve FY25 audited financials; trading window reopening noted.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 20Th May 2025
2d - TCM Ltd to acquire 100% shares of Better Feeds Pvt Ltd, subject to valuation and due diligence.
-
Intimation Under Regulation 30 Of The SEBI(LODR) Regulations 2015-Penal Action For Delayed Compliance
15 May - Rs. 2,000 fine for one-day delay in shareholding pattern filing for Q4 FY25.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
22 Apr - TCM Limited confirms it is not a Large Corporate for FY 2025-26 as per SEBI criteria.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1]
Company trading of medical products,
GPS-enabled Automatic Headlight Beam Assist System for vehicles under the brand name of ENSO, and the business of setting up and commissioning Solar Power plants